Ehlers, Lisa
Rolfes, Elisabeth
Lieber, Mareike
Müller, Dominik
Lainka, Elke
Gohar, Faekah
Klaus, Günter
Girschick, Hermann
Hörstermann, Jana
Kümmerle-Deschner, Jasmin
Brunner, Jürgen
Palm-Beden, Katharina
Tenbrock, Klaus
von Wrangel, Lusine
Faßhauer, Maria
Blank, Norbert
Trauzeddel, Ralf
von Stuckrad, Anne Sae Lim
Higgins, Sonja
Welzel, Tatjana
Lutz, Thomas
Hentgen, Véronique
Foell, Dirk
Wittkowski, Helmut
Kallinich, Tilmann http://orcid.org/0000-0003-2404-9397
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Received: 10 November 2022
Accepted: 11 August 2023
First Online: 26 September 2023
Declarations
:
: Not applicable.
: Not applicable.
: Lisa Ehlers has no conflicts of interest to declare. Elisabeth Rolfes has no conflicts of interest to declare. Mareike Lieber is a member of the following medical society: GKJR. Dominik Müller has no conflicts of interest to declare. Elke Lainka received consulting fees from Mirum and Albireo. Faekah Gohar has no conflicts of interest to declare. Günter Klaus has no conflicts of interest to declare. Hermann Girschick was involved in the development of treatment guidelines of the following societies: DGKJ. Jana Hörstermann has no conflicts of interest to declare. Jasmin Kümmerle-Deschner received consulting fees, honoraria and research grants from Novartis and SOBI, and is a member of the following medical societies: GKJR, DGRh, PRES, ISSAID. Jürgen Brunner received honoraria for presenting at industrial symposia and is a member of the following medical societies: DGKJ, ÖGKJ, ÖGR, GKJR, DGPI. Katharina Palm-Beden has no conflicts of interest to declare. Klaus Tenbrock received consulting fees from Pfizer and Novartis, a research grant from Pfizer, and was involved in the development of treatment guidelines of the following societies: GKJR. Lusine von Wrangel has no conflicts of interest to declare. Maria Faßhauer has no conflicts of interest to declare. Norbert Blank received consulting fees, honoraria and research grants from Novartis and SOBI, and is a member of the following medical societies: DGRh, DNSS, ISA. Ralf Trauzeddel received consulting fees from Novartis and was involved in the development of a treatment guideline of the following society: AWMF. Anne Sae Lim von Stuckrad has no conflicts of interest to declare. Sonja Higgins has no conflicts of interest to declare. Tatjana Welzel has no conflicts of interest to declare. Thomas Lutz is a member of the following medical societies: GKJR, DGKJ, DGPI. Véronique Hentgen has received consulting fees and honoraria from Novartis and SOBI, is a member of the steering committee of the JIRcohort which received public and private funding for research, and is involved in the development of French guidelines on behalf of the Haute Autorité de Santé (HAS). She is a member of the following medical societies:SOFREMIP, PReS and ISSAID. Dirk Foell received research funding from Novartis and Sobi, honoraria from Novartis and Sobi, and is a member of the following medical societies: GKJR, API, ISSAID, PReS, GPGE, and DGKJ. Helmut Wittkowski received research funding from Takeda, honoraria from Novartis and Takeda, travel grants from Octapharma and CSL-Behring, and is a member of the following medical societies: GKJR, API. Tilmann Kallinich is a member of the following medical societies: GKJR and DGPI.